FDA Approved: OXISTAT — Supplemental Application (ANI Pharmaceuticals, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for OXISTAT (oxiconazole nitrate) submitted by ANI Pharmaceuticals, Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pityriasis Versicolor
• Tinea Corporis
• Tinea Cruris
• Tinea Pedis

Drugs mentioned

• OXISTAT (OXICONAZOLE NITRATE)

Snippet

SUPPL AP for OXISTAT (OXICONAZOLE NITRATE)